WASHINGTON, May 4, 2023
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:
VNDA) today announced participation at Digestive Disease Week (DDW)
2023, to be held in Chicago, IL
and online from May 6-9, 2023.
The following will be presented:
May 7, 2023
Presentation Title: "THE ROLE OF TENASCIN-X IN IDIOPATHIC
GASTROPARESIS: WGS ANALYSIS"
Poster Number: Su1618
Presenter: Dr. Sandra Paulina
Smieszek, Head of Genetics
Session Type: Poster Session
Session Title: AGA Gastroparesis and Small Intestinal
Dysmotility
Session Time: 12:30 PM to 1:30 PM
CDT
Presentation Title: "POOLED EFFICACY ANALYSIS OF TRADIPITANT IN
IDIOPATHIC AND DIABETIC GASTROPARESIS STUDY VP-VLY-686-3301 AND
VP-VLY-686-2301"
Poster Number: Su1632
Presenter: Dr. Jesse L. Carlin,
Clinical Project Lead
Session Type: Poster Session
Session Title: AGA Gastroparesis and Small Intestinal
Dysmotility
Session Time: 12:30 PM to 1:30 PM
CDT
Presentation Title: "EFFICACY ANALYSIS OF TRADIPITANT IN
IDIOPATHIC AND DIABETIC GASTROPARESIS IN STUDY VP-VLY-686-3301"
Poster Number: Su1633
Presenter: Dr. Jesse L. Carlin,
Clinical Project Lead
Session Type: Poster Session
Session Title: AGA Gastroparesis and Small Intestinal
Dysmotility
Session Time: 12:30 PM to 1:30 PM
CDT
Presentation Title: "A BASELINE SEVERITY INFLATION ANALYSIS IN
STUDY VP-VLY-686-3301 OF TRADIPITANT IN GASTROPARESIS"
Poster Number: Su1634
Presenter: Dr. Jesse L. Carlin,
Clinical Project Lead
Session Type: Poster Session
Session Title: AGA Gastroparesis and Small Intestinal
Dysmotility
Session Time: 12:30 PM to 1:30 PM
CDT
For more information on DDW 2023, please refer to
https://ddw.org/.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
Kevin
Moran
Senior Vice President, Chief Financial Officer and
Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original
content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-presentations-at-ddw-2023-301816683.html
SOURCE Vanda Pharmaceuticals Inc.